We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
Cap. Flow
-$301M
Cap. Flow %
-0.68%
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
MSFT icon
Microsoft
MSFT
+$204M
3
JNJ icon
Johnson & Johnson
JNJ
+$157M
4
AMZN icon
Amazon
AMZN
+$144M
5
WMT icon
Walmart Inc
WMT
+$137M

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Healthcare 16.49%
3 Financials 11.74%
4 Industrials 11.47%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTCH
2151
DELISTED
Latch, Inc. Common Stock
LTCH
$30K ﹤0.01%
+26,727
New +$68.4K
AXDX
2152
DELISTED
Accelerate Diagnostics
AXDX
$28K ﹤0.01%
2,810
-1,574
-36% -$13.9K
CIFR icon
2153
Cipher Digital
CIFR
$6.94B
$27K ﹤0.01%
19,977
-1,729
-8% -$4.21K
XXII
2154
22nd Century Group
XXII
$1.48M
0
DOMA
2155
DELISTED
Doma Holdings, Inc.
DOMA
$26K ﹤0.01%
996
-128
-11% -$5.44K
CDZI icon
2156
Cadiz
CDZI
$280M
$25K ﹤0.01%
10,859
RKLY
2157
DELISTED
Rockley Photonics Holdings Limited
RKLY
$25K ﹤0.01%
11,624
-8,161
-41% -$25K
QMCO icon
2158
Quantum Corp
QMCO
$459M
$24K ﹤0.01%
+860
New +$32.6K
WGS icon
2159
GeneDx Holdings
WGS
$2.34B
$24K ﹤0.01%
582
CTXR icon
2160
Citius Pharmaceuticals
CTXR
$18.5M
$23K ﹤0.01%
+1,011
New +$27.7K
GET
2161
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
$22K ﹤0.01%
13,375
-1,025
-7% -$1.62K
HIPO icon
2162
Hippo Holdings
HIPO
$854M
$21K ﹤0.01%
964
-425
-31% -$15.7K
MBIO icon
2163
Mustang Bio
MBIO
$4.46M
$21K ﹤0.01%
48
+26
+118% +$14.4K
BARK icon
2164
BARK
BARK
$100M
$20K ﹤0.01%
774
-420
-35% -$21.2K
QTNT
2165
DELISTED
Quotient Limited Ordinary Shares
QTNT
$20K ﹤0.01%
2,068
+1,732
+515% +$37K
GOEV
2166
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$19K ﹤0.01%
+23
New +$40.4K
BCEL
2167
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$18K ﹤0.01%
+10,211
New +$21.3K
VBIV
2168
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$17K ﹤0.01%
+693
New +$23.6K
SIEN
2169
DELISTED
Sientra, Inc.
SIEN
$17K ﹤0.01%
2,032
+732
+56% +$9.97K
ZOM
2170
DELISTED
Zomedica Corp.
ZOM
$16K ﹤0.01%
71,096
-21,311
-23% -$5.43K
APLT
2171
DELISTED
Applied Therapeutics
APLT
$13K ﹤0.01%
13,907
-71,157
-84% -$117K
ARDX icon
2172
Ardelyx
ARDX
$977M
$12K ﹤0.01%
+20,125
New +$14.8K
AEIS icon
2173
Advanced Energy
AEIS
$12.9B
-4,038
Closed -$348K
AIR icon
2174
AAR Corp
AIR
$5.79B
-4,277
Closed -$207K
ALLO icon
2175
Allogene Therapeutics
ALLO
$714M
-73,717
Closed -$672K

Similar funds

AQR Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
  • AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
  • AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
  • AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
  • AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
  • AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
  • AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.